STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
75 hedge funds and large institutions have $119M invested in Stemline Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 74 → 75 (+1)
Holders
75
Holding in Top 10
–
Calls
$2.41M
Puts
$1.18M
Top Buyers
| 1 | +$10.4M | |
| 2 | +$9.09M | |
| 3 | +$7.78M | |
| 4 |
Axa
Paris,
France
|
+$3.71M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$2.81M |
Top Sellers
| 1 | -$2.61M | |
| 2 | -$1.81M | |
| 3 | -$1.01M | |
| 4 |
VMI
VHCP Management II
New York
|
-$751K |
| 5 |
Renaissance Technologies
New York
|
-$701K |